A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level.
Vis DJ, Jaaks P, Aben N, Coker EA, Barthorpe S, Beck A, Hall C, Hall J, Lightfoot H, Lleshi E, Mironenko T, Richardson L, Tolley C, Garnett MJ, Wessels LFA.
Vis DJ, et al. Among authors: coker ea.
Cell Rep Med. 2024 Aug 20;5(8):101687. doi: 10.1016/j.xcrm.2024.101687.
Cell Rep Med. 2024.
PMID: 39168097
Free PMC article.